Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives

Hypertension

Volumn 33, Issue 2, 1999, Pages 658-662

  Dessì Fulgheri, Paolo ^a,b   Sarzani, Riccardo ^a   Serenelli, Massimiliano ^a   Tamburrini, Paola ^a   Spagnolo, Diego ^a   Giantomassi, Laura ^a   Espinosa, Emma ^a   Rappelli, Alessandro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Atrial; Cyclic GMP; Diuresis; Hypertension; Natriuresis; Natriuretic peptides; Obesity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; LOW CALORY DIET; MALE; NATRIURESIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0344573096     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.2.658     Document Type: Article

References (32)

1. Krieger DR, Landsberg L. Obesity and hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:2367-2388.
2. Stamler RA, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure findings in hypertension screening of 1 million Americans. JAMA. 1978;240:1607-1610.
3. MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 1987;8(suppl B):57-70.
4. Havlik RJ, Hubert HB, Fabsitz RR, Feinleb M. Weight and hypertension. Ann Intern Med. 1983;98:855-859.
5. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity induced hypertension: renal function and systemic hemodynamics. Hypertension. 1993; 22:292-299.
6. Reisin E, Messerli FH. Obesity-related hypertension: mechanisms, cardiovascular risks, and heredity. Curr Opin Nephrol Hypertens. 1995;4: 67-71.
7. Rocchini AP, Moorehead CP, DeRemer S, Bondie D. Pathogenesis of weight related changes in blood pressure in dogs. Hypertension. 1989; 13:922-928.
8. Rocchini AP. Insulin resistance and blood pressure regulation in obese and non-obese subjects. Hypertension. 1991;17:837-842.
9. Rocchini AP, Key S, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescent. N Engl J Med. 1989;321:580-585.
10. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978; 298:1-6.
11. Sigler MH. The mechanism of the natriuresis of fasting. J Clin Invest. 1975;55:377-387.
12. Spark RF, Arky RA, Boutler PA, Saudek CD, O'Brian JT. Renin, aldosterone and glucagon in the natriuresis of fasting. N Engl J Med. 1975; 292:1335-1340.
13. Richards AM. The natriuretic peptides and hypertension. J Intern Med. 1994;235:543-560.
14. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system, II: natriuretic peptide receptors. J Hypertens. 1992;10:1111-1118.
15. Maack T. Receptors of natriuretic peptides: structure, function, and regulation. In: Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:1001-1019.
16. Licata G, Volpe M, Scaglione R, Rubattu S. Salt-regulating hormones in young normotensive obese subjects: effects of saline load. Hypertension. 1994;23(suppl I):I-20-I-24.
17. Maoz E, Shamiss A, Peleg E, Salzberg M, Rosenthal T. The role of atrial natriuretic peptide in the natriuresis of fasting. J Hypertens. 1992;10: 1041-1044.
18. Jeandel L, Okamura H, Belles-Isles M, Chabot JG, Dihl F, Morel G, Kelly PA, Heisler S. Immunocytochemical localization, binding, and effects of atrial natriuretic peptide in rat adipocytes. Mol Cell Endocrinol. 1989;62:69-78.
19. Bacay AC, Mantyh CR, Vigna SR, Mantyh PW. Receptor binding sites for atrial natriuretic factor are expressed by brown adipose tissue. Peptides. 1988;9:1021-1026.
20. Sarzani R, Dessì-Fulgheri P, Paci MV, Espinosa E, Rappelli A. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest. 1996;19:581-585.
21. Sarzani R, Paci MV, Dessì-Fulgheri P, Espinosa E, Rappelli A. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J Hypertens. 1993;11(suppl 5):S214-S216.
22. de Leon H, Bonhomme M-C, Thibault G, Garcia R. Localization of atrial natriuretic factors receptors in the mesenteric arterial bed: comparison with angiotensin II and endothelin receptors. Circ Res. 1995;77:64-72.
23. Sarzani R, Paci MV, Zingaretti C, Pierleoni C, Cinti S, Cola G, Rappelli A, Dessì-Fulgheri P. Fasting inhibits natriuretic peptide clearance receptor expression in rat adipose tissue. J Hypertens. 1995;13: 1241-1246.
24. Dessì-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15: 1695-1699.
25. Crandall DL, Ferraro GD, Cervoni P. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc Soc Exp Biol Med. 1989;191:352-356.
26. 2) and triceps skinfold thickness. Am J Clin Nutr. 1991;53:839-846.
27. Office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care. 1995;8(suppl 1):4-7.
28. Waldhausl W, Vierhapper H, Nowotny P. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis. J Clin Endocrinol Metab. 1986;62:956-959.
29. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 1989;2:1255-1325.
30. Tuck ML. Obesity, the sympathetic nervous system and essential hypertension. Hypertension. 1992;19(suppl I):I-167-I-177.
31. Higuchi K, Nawata H, Kato K, Ibayashi H, Matsuo H. α-Human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. J Clin Endocrinol Metab. 1986;62:941-944.
32. Anderson JV, Struthers AD, Payne NN, Slater JD, Bloom SR. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci. 1986;70:507-510.